Besides these biochemical pathways, recent studies have also highlighted the impact of Se and certain selenoproteins on the endocrine control of hormone-responsive tumors, i.e., prostate and gynecological malignancies, and in particular breast and thyroid cancer [34,[52], [53], [54]]. Here, SELENOS is linked to thyroid gland carcinoma.